Legacy Financial Advisors Inc. Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legacy Financial Advisors Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.4% during the 4th quarter, HoldingsChannel reports. The fund owned 2,325 shares of the medical equipment provider’s stock after purchasing an additional 237 shares during the period. Legacy Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $1,214,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Hurley Capital LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $522.95 on Thursday. The stock has a 50-day moving average of $536.22 and a two-hundred day moving average of $532.26. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market cap of $186.26 billion, a P/E ratio of 81.58, a P/E/G ratio of 5.85 and a beta of 1.55.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.